Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

Reliability of programmed death ligand 1 (PD-L1) tumor proportion score (TPS) on cytological smears in advanced non-small cell lung cancer: a prospective validation study

Introduction: Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assessment is mandatory for the single agent pembrolizumab treatment of patients with advanced non-small cell lung cancer (NSCLC). PD-L1 testing has been validated and is currently certified only on formalin-fixed paraffin-em...

Full description

Bibliographic Details
Main Authors: Costantino Ricci, Elisa Capizzi, Francesca Giunchi, Laura Casolari, Francesco Gelsomino, Karim Rihawi, Filippo Natali, Vanina Livi, Rocco Trisolini, Michelangelo Fiorentino, Andrea Ardizzoni
Format: Article
Language:English
Published: SAGE Publishing 2020-11-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835920954802

Internet

https://doi.org/10.1177/1758835920954802

Similar Items